Home › Trial NCT00122681
Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18
- Trial IDNCT00122681
- StatusCompleted
- PhasePhase 3
- Study typeInterventional
- SponsorGlaxoSmithKline
- Enrollment18729
- Start date2004-05-06
- ConditionsInfections, Papillomavirus
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.